Phase Biolabs Analysis
What is Phase Biolabs?
Phase Biolabs engineers patented gas fermentation biotechnology that converts captured carbon dioxide into ethanol, chemicals, and sustainable fuels. The company positions its system as a retrofit for existing industrial and ethanol plants, with pilot operations in Nottingham and a stated mission to upcycle 1 gigaton of CO2 by 2050. Its Valorise offering models plant economics using Phase assumptions, including D5 RINs and ethanol production estimates.
Location
Applied Health Research Building, University Boulevard, Nottingham, NG7 2RD, United Kingdom
Employees
1-10
Founded
2020
Revenue
$0-5M
Company Stage
Pre-Seed
YC Batch
W22
Product Features & Capabilities
- transforming waste CO2 into valuable chemicals and fuels, gas fermentation process using patented microbes, retrofits on existing setups, works with any CO2 source, microorganisms that are six times more efficient and 100 times faster at converting CO2 into electrofuels.
Who are the founders of Phase Biolabs
DO
David Ortega
Founder & CTO
HQ Full Address
Applied Health Research Building, University Boulevard, Nottingham, NG7 2RD, United Kingdom
Investors
- Breakthrough Energy
- Asymmetry Ventures
- Transition Global
- Zillionize
- Y Combinator
Market Focus
Phase Biolabs primarily focuses on the biotechnology industry, specifically in the area of transforming CO2 emissions into valuable products through gas fermentation processes that produce chemicals and fuels.
Competitors Overview
Phase Biolabs operates in the biotechnology sector, focusing on converting waste CO2 emissions into valuable chemicals and fuels. Its main competitors include:
-
Evonik: A leading specialty chemicals company that collaborates with Siemens to convert CO2 into specialty chemicals using renewable electricity and bacteria. Their technology is noted for its efficiency and ability to reduce atmospheric CO2 levels.
-
LanzaTech: This company utilizes a flexible and efficient process that can handle various feedstocks, including municipal solid waste and industrial offgases, converting them into ethanol. Their technology is distinguished by its adaptability and minimal processing requirements.
-
Solugen: Although specific details about their CO2 conversion technology were not found, they are known for producing hydrogen peroxide from plant sugars, which may offer a different approach to sustainable chemical production.
-
Strella Biotechnology: This company focuses on biotechnological solutions for CO2 conversion, but specific advantages or technologies were not detailed in the search results.
-
iECURE: They are involved in CO2 conversion technologies, emphasizing the development of efficient systems for transforming CO2 into useful products, although specific advantages were not highlighted.
-
Pow.bio: They offer a high-efficiency fermentation platform that decouples growth and production, addressing contamination and genetic drift issues. This platform allows for rapid market entry and competitive cost advantages.
Notable differences include Evonik's focus on specialty chemicals and renewable energy integration, LanzaTech's versatility in feedstock processing, and Pow.bio's innovative fermentation technology that enhances production efficiency.
Business Model
Revenue from selling CO2 conversion technology and sustainable chemical products to emitters.
See something that needs updating? Suggest edits to this profile.